Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Suaad Abdallah Audat, Qosay Ali Al-Balas, Buthina Abdallah Al-Oudat, Mo’ad Jamil Athamneh & Amanda Bryant-Friedrich. (2022) Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors. Drug Design, Development and Therapy 16, pages 873-885.
Read now
Read now
Articles from other publishers (16)
Yan Xu, Xiaojun Zhou, Ling Gao, Su Yan, Zhenyun Li, Daiyi Zhang, Jianhong Pu, Shitao Zou & Zhongqi Mao. (2022) Identification of HAGHL as a novel metabolic oncogene regulating human colorectal cancer progression. Clinical and Translational Oncology 25:4, pages 1033-1042.
Crossref
Crossref
Qosay A. Al‑Balas, Mahmoud A. Al-Sha'er, Mohammad A. Hassan & Esra’a Al Zou’bi. (2022) Identification of the First “Two Digit Nano-molar” Inhibitors of the Human Glyoxalase-I Enzyme as Potential Anticancer Agents. Medicinal Chemistry 18:4, pages 473-483.
Crossref
Crossref
Buthina A. Al-Oudat, Nizar A. Al-Shar'i, Qosay A. Al‑Balas, Suaad A. Audat, Mohammad A.Y. Alqudah, Ali H. Hamzah, Ramez W. Hallak, Mel Bedi & Amanda Bryant-Friedrich. (2022) Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents. Bioorganic Chemistry 120, pages 105657.
Crossref
Crossref
Phattarunda Jaree, Pakpoom Boonchuen, Jumroensri Thawonsuwan, Hidehiro Kondo, Ikuo Hirono & Kunlaya Somboonwiwat. (2022) Transcriptome profiling reveals the novel immunometabolism-related genes against WSSV infection from Fenneropenaeus merguiensis. Fish & Shellfish Immunology 120, pages 31-44.
Crossref
Crossref
Nadia Taïbi, Qosay Ali Al-balas, Nadjia Bekari, Oualid Talhi, Ghazi Ahmad Al Jabal, Yasmine Benali, Rachid Ameraoui, Mohamed Hadjadj, Amina Taïbi, Zahra Mouna Boutaiba, Mohamed Abou-Mustapha, Farida Khammar, Fayçal Dergal, Ridha Hassaine, Leila Boukenna, Khaldoun Bachari & Artur Manuel Soares Silva. (2021) Molecular docking and dynamic studies of a potential therapeutic target inhibiting glyoxalase system: Metabolic action of the 3, 3 '- [3- (5-chloro-2-hydroxyphenyl) -3-oxopropane-1, 1-diyl] - Bis-4-hydroxycoumarin leads overexpression of the intracellular level of methylglyoxal and induction of a pro-apoptotic phenomenon in a hepatocellular carcinoma model. Chemico-Biological Interactions 345, pages 109511.
Crossref
Crossref
Nizar A. Al-Shar’i, Qosay A. Al-Balas, Mohammad A. Hassan, Tamam M. El-Elimat, Ghazi A. Aljabal & Ammar M. Almaaytah. (2021) Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold. Acta Pharmaceutica 71:1, pages 115-130.
Crossref
Crossref
Yujiao He, Chunyan Zhou, Maolin Huang, Chunyan Tang, Xiao Liu, Yan Yue, Qingchun Diao, Zhebin Zheng & Deming Liu. (2020) Glyoxalase system: A systematic review of its biological activity, related-diseases, screening methods and small molecule regulators. Biomedicine & Pharmacotherapy 131, pages 110663.
Crossref
Crossref
Buthina A. Al-Oudat, Hana'a M. Jaradat, Qosay A. Al‑Balas, Nizar A. Al-Shar'i, Amanda Bryant-Friedrich & Mel F. Bedi. (2020) Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents. Bioorganic & Medicinal Chemistry 28:16, pages 115608.
Crossref
Crossref
Louvy Lynn Punzalan, Lulu Jiang, Di Mao, Amarjyoti Das Mahapatra, Shinichi Sato, Yasushi Takemoto, Mari Tsujimura, Kosuke Kusamori, Makiya Nishikawa, Lu Zhou & Motonari Uesugi. (2020) Chemoproteomic Profiling of a Pharmacophore-Focused Chemical Library. Cell Chemical Biology 27:6, pages 708-718.e10.
Crossref
Crossref
Nizar A. Al-Shar’i, Enas K. Al-Rousan, Lara I. Fakhouri, Qosay A. Al-Balas & Mohammad A. Hassan. (2019) Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking. Medicinal Chemistry Research 29:3, pages 356-376.
Crossref
Crossref
Tian Jin, Lu Zhao, Hong-Ping Wang, Mao-Lin Huang, Yan Yue, Chichong Lu & Zhe-Bin Zheng. (2020) Recent advances in the discovery and development of glyoxalase I inhibitors. Bioorganic & Medicinal Chemistry 28:4, pages 115243.
Crossref
Crossref
Nizar A. Al-Shar’i, Qosay A. Al-Balas, Rand A. Al-Waqfi, Mohammad A. Hassan, Amer E. Alkhalifa & Nehad M. Ayoub. (2019) Discovery of a nanomolar inhibitor of the human glyoxalase-I enzyme using structure-based poly-pharmacophore modelling and molecular docking. Journal of Computer-Aided Molecular Design 33:9, pages 799-815.
Crossref
Crossref
Patricia Mendonca, Equar Taka & Karam Soliman. (2019) Proteomic analysis of the effect of the polyphenol pentagalloyl glucose on proteins involved in neurodegenerative diseases in activated BV‑2 microglial cells. Molecular Medicine Reports.
Crossref
Crossref
Mahmoud A. Al-Sha'er, Qosay A. Al-Balas, Mohammad A. Hassan, Ghazi A. Al Jabal & Ammar M. Almaaytah. (2019) Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents. Computational Biology and Chemistry 80, pages 102-110.
Crossref
Crossref
Christian Perez, Amanda M. Barkley-Levenson, Benjamin L. Dick, Peter F. Glatt, Yadira Martinez, Dionicio Siegel, Jeremiah D. Momper, Abraham A. Palmer & Seth M. Cohen. (2019) Metal-Binding Pharmacophore Library Yields the Discovery of a Glyoxalase 1 Inhibitor. Journal of Medicinal Chemistry 62:3, pages 1609-1625.
Crossref
Crossref
Qosay A. Al‐Balas, Mohammad A. Hassan, Nizar A. Al‐Shar'i, Tamam El‐Elimat & Ammar M. Almaaytah. (2017) Computational and experimental exploration of the structure–activity relationships of flavonoids as potent glyoxalase‐I inhibitors. Drug Development Research 79:2, pages 58-69.
Crossref
Crossref